The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Omalizumab
Australian Public Assessment Report
Device/Product Name
Xolair
Active ingredients
Omalizumab
AusPAR Date
Published
Submission Number
PM-2019-05980-1-5
Submission Type
Extension of indication
Decision
Approved